KH
Kilele Health Inc.
SEC filingBiotechnology · Oakwood, OH
Amount raised$265Ksold at filing
Total offering$2M$1.7M still open
Investors in the raise3count reported to the SEC
FiledOct 1, 2025first sale Sep 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jason Charles HeikenfeldExecutive Officer, Director, Promoter
Sven Charles SchreiberExecutive Officer
Andrew David CothrelExecutive Officer, Director, Promoter
Brittany Nicole ArdeExecutive Officer
Executive officers, directors and promoters as listed on the Form D.